Melissa M. Dimilta
Intellectual Property, National Practice Group Leader

Outline
Melissa Dimilta is an experienced intellectual property litigator and strategist. Melissa advises clients on all types of intellectual property including, patents, trademarks, copyrights and industrial design and on life science regulatory issues.
Overview
Client Work
Shift4 Payments and its affiliates in their acquisition of Bambora Inc., Bambora Holding Corp., Bambora Corp. and Worldline SMB US
Amgen Canada Inc. in the first motion to delist a patent under the new Patented Medicines (Notice of Compliance Regulations) (Bayer Inc v Amgen Canada Inc, 2024 FC 1849)
Amgen Canada Inc. in a judicial review application brought by Bayer Inc. (Bayer Inc. v Amgen Canada Inc., 2025 FC 107 aff'd 2025 FCA 142)
Amgen Canada Inc. on a motion to compel samples brought by Bayer Inc. and Regeneron Pharmaceuticals Inc. (2025 FC 264)
Amgen Canada Inc. in five different actions brought by Bayer Inc. and Regeneron Pharmaceuticals Inc. under the Patented Medicines (Notice of Compliance Regulations) related to the drug aflibercept
Alexa Translations in its trademark infringement action against Amazon.com
Recognitions & Awards
The Legal 500 Canada
Key Lawyer, Cannabis
Managing IP: IP Stars
Recognized as a Rising Star – Canada
WTR 1000 The World's Leading Trademark Professionals
Recognized among the top 1000 Trademark professionals in Prosecution and Strategy
Related Services
Education & Bar Admissions
Education
- University of Toronto, BSc (Hons), 2007
- University of Windsor, JD, 2011
Bar Admissions
- Ontario, 2012
Insights
Blog
Canada Accelerates Regulatory Modernization
May 26, 2026Melissa M. Dimilta, Benjamin K. Reingold & Emma Danaher
News, Events & Speaking Engagements
Speaking Engagement
Bennett Jones at CBA IP Day 2026
May 29, 2026Benjamin K. Reingold & Melissa M. Dimilta
Announcement
Bennett Jones Recognized at the Managing IP Americas Awards 2026
April 9, 2026Dominique T. Hussey, Melissa M. Dimilta & Emily P. Kettel









